Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 13.79% |
| 3 | Financials | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETRN
776
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $61.1M | 0.02% |
7,356,877
+2,036,118
| +38% | +$16M |
|
777
Kinross Gold
KGC
$32.6B
| $61.1M | 0.02% |
8,467,496
+2,431,048
| +40% | +$15.8M |
|
|
CLGX
778
DELISTED
Corelogic, Inc.
CLGX
| $61.1M | 0.02% |
908,249
+20,247
| +2% | +$900K |
|
|
EV
779
DELISTED
Eaton Vance Corp.
EV
| $60.9M | 0.02% |
1,576,818
-48,148
| -3% | -$1.75M |
|
|
LM
780
DELISTED
Legg Mason, Inc.
LM
| $60.5M | 0.02% |
1,216,374
+16,767
| +1% | +$833K |
|
781
TC Energy
TRP
$66.3B
| $60.4M | 0.02% |
1,408,480
+195,431
| +16% | +$8.77M |
|
782
Acadia Healthcare
ACHC
$2.95B
| $60.4M | 0.02% |
2,402,989
+77,549
| +3% | +$1.94M |
|
|
PCH
783
DELISTED
PotlatchDeltic
PCH
| $60.2M | 0.02% |
1,582,768
+12,144
| +0.8% | +$411K |
|
784
Emcor
EME
$36.8B
| $60.1M | 0.02% |
908,459
-44,515
| -5% | -$2.79M |
|
785
Flowers Foods
FLO
$1.52B
| $59.9M | 0.02% |
2,678,386
-721,891
| -21% | -$16.3M |
|
786
EastGroup Properties
EGP
$10.9B
| $59.9M | 0.02% |
504,862
+779
| +0.2% | +$86.1K |
|
787
Jones Lang LaSalle
JLL
$17B
| $59.8M | 0.02% |
578,030
+11,904
| +2% | +$1.23M |
|
788
Diamondback Energy
FANG
$55.9B
| $59.6M | 0.02% |
1,425,697
+74,956
| +6% | +$3.06M |
|
789
Middleby
MIDD
$5.38B
| $59.6M | 0.02% |
754,687
+525,790
| +230% | +$34.1M |
|
790
Paylocity
PCTY
$8.1B
| $59.5M | 0.02% |
408,135
+264,472
| +184% | +$30.8M |
|
791
United Therapeutics
UTHR
$21.9B
| $59.2M | 0.02% |
489,249
+18,893
| +4% | +$2.13M |
|
792
Ultragenyx Pharmaceutical
RARE
$2.65B
| $59.1M | 0.02% |
755,149
+50,733
| +7% | +$3.36M |
|
793
Burlington
BURL
$22.3B
| $59M | 0.02% |
299,381
-14,317
| -5% | -$2.7M |
|
794
KKR & Co
KKR
$103B
| $58.6M | 0.02% |
1,896,492
+866,260
| +84% | +$23.3M |
|
795
ASML
ASML
$710B
| $58.2M | 0.02% |
158,101
-158,742
| -50% | -$49.8M |
|
|
DNKN
796
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $58.2M | 0.02% |
891,642
-105,477
| -11% | -$6.56M |
|
797
Autohome
ATHM
$2.65B
| $58M | 0.02% |
767,880
+6,496
| +0.9% | +$508K |
|
|
BHVN
798
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $57.9M | 0.02% |
792,561
+91,467
| +13% | +$4.87M |
|
|
DISH
799
DELISTED
DISH Network Corp.
DISH
| $57.9M | 0.02% |
1,676,327
+78,396
| +5% | +$2.18M |
|
800
Brookfield
BN
$111B
| $57.8M | 0.02% |
3,281,879
+73,521
| +2% | +$1.29M |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.